Domainex Ltd, St George’s Hospital (University of London), and The University of Manchester have announced that they are collaborating on a new drug discovery programme to provide a better treatment for asthma. Domainex will provide lead optimisation services for an asthma research programme being undertaken at St George’s. The total contract value for Domainex is around £1.5 million in research fees over two years. St George’s Hospital and The University of Manchester have recently been awarded a £4 million research grant from the Wellcome Trust’s Seeding Drug Discovery Initiative to take this research programme forward. Founded in 2002, Domainex specializes in the provision of protein science and medicinal chemistry services to large pharmaceutical and biotechnology companies and to academic research groups. The company is also developing a pipeline of pre-clinical drugs and targets.
June 30, 2009...8:41 am
Domainex announces academic asthma treatment collaboration
Jump to Comments
